On Jan. 24, the Federal Trade Commission (FTC) published a notice in the Federal Register revising the premerger notification thresholds for mergers and acquisitions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR Act). Also on Jan. 24, the FTC published revisions to the thresholds that trigger, under Section 8 of the Clayton…

For the 3rd consecutive year, GT’s Tel Aviv office and members of the firm’s Israel Practice have been recognized by IsraelDesks‘ Legally Israel 100 directory.
Our Israel team has been recognized in the below categories:

…

We are pleased to announce that in the recently released ranking by Israeli league table Legally Israel 100, Greenberg Traurig’s Tel Aviv office has been recognized in nine categories, more than any other firm recognized in this year’s rankings. These areas include M&A Volume, M&A Value, Real Estate, Litigation, Employment, IP, Capital Markets, Venture …

Life sciences companies should pay attention to an ongoing action in Delaware that could have implications for whether they can obtain (or be subjected to) U.S. discovery in international arbitration under 28 U.S.C. § 1782. Section 1782 is a powerful tool that permits litigants to obtain broad discovery in the United States for use in…

GT is pleased to have achieved a win on behalf of our client Teva Pharmaceuticals USA, Inc.

In May 2018, a U.S. Federal District Court Judge from the Central District of California granted Teva’s motion to dismiss in its entirety without leave to amend.

In April 2017, Plaintiffs commenced an action in California’s Riverside County …